SHA:603229 Market Cap

SHA:603229 has a market cap or net worth of 7.71 billion as of March 9, 2026. Its market cap has increased by 3.20% in one year.

Market Cap

7.71B

Enterprise Value

6.95B

Revenue

751.12M

Ranking

n/a

PE Ratio

42.05

Stock Price

9.31

Market Cap Chart

Since May 9, 2017, SHA:603229's market cap has increased from 1.80B to 7.71B, an increase of 328.41%. That is a compound annual growth rate of 17.89%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	7.71B	-6.15%
Dec 31, 2025	8.22B	-0.94%
Dec 31, 2024	8.29B	5.87%
Dec 29, 2023	7.83B	-18.09%
Dec 30, 2022	9.56B	-8.49%
Dec 31, 2021	10.45B	19.25%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Suzhou Fengbei Biotech Stock	7.92B
Anhui Huaheng Biotechnology	7.99B
Nanjing Vazyme Biotech	8.06B
Chengdu Kanghua Biological Products	8.08B
Acrobiosystems	7.53B
Wuhan Keqian Biology Co.,Ltd	7.43B
Jiangxi Fushine Pharmaceutical	8.25B
Youcare Pharmaceutical Group	8.43B

Market Cap Rankings